• +1-646-491-9876
    • +91-20-67278686

    Search

    Chronic Bronchitis Global Clinical Trials Review H1 2017

    Chronic Bronchitis Global Clinical Trials Review H1 2017

    • Report Code ID: RW00011016481
    • Category Life Sciences
    • No. of Pages 134
    • Publication Month Jun-17
    • Publisher Name GlobalData
    Chronic Bronchitis Global Clinical Trials Review, H1, 2017

    Summary

    GlobalData's clinical trial report, "Chronic Bronchitis Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80 different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

    The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

    -Note-Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    -The report provides a snapshot of the global clinical trials landscape
    -Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    -The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    -The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    -The Report provides enrollment trends for the past five years
    -Report provides latest news for the past three months

    -Note-Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Reasons to buy

    -Assists in formulating key business strategies with regards to investment
    -Helps in identifying prominent locations for conducting clinical trials which saves time and cost
    -Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
    -Supports understanding of trials count and enrollment trends by country in global therapeutics market
    -Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    -Facilitates clinical trial assessment of the indication on a global, regional and country level

    -Note-Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
    Table of Contents
    Table of Contents 2
    List of Tables 3
    List of Figures 3
    Report Guidance 4
    GlobalData Clinical Trials Report Coverage 5
    Clinical Trials by Region 6
    Clinical Trials and Average Enrollment by Country 7
    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
    Top Five Countries Contributing to Clinical Trials in Europe 11
    Top Countries Contributing to Clinical Trials in North America 12
    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
    Top Five Countries Contributing to Clinical Trials in Central and South America 14
    Clinical Trials by G7 Countries-Proportion of Chronic Bronchitis to Respiratory Clinical Trials 15
    Clinical Trials by Phase in G7 Countries 16
    Clinical Trials in G7 Countries by Trial Status 17
    Clinical Trials by E7 Countries-Proportion of Chronic Bronchitis to Respiratory Clinical Trials 18
    Clinical Trials by Phase in E7 Countries 19
    Clinical Trials in E7 Countries by Trial Status 20
    Clinical Trials by Phase 21
    In Progress Trials by Phase 22
    Clinical Trials by Trial Status 23
    Clinical Trials by End Point Status 25
    Subjects Recruited Over a Period of Time 26
    Clinical Trials by Sponsor Type 27
    Prominent Sponsors 28
    Top Companies Participating in Chronic Bronchitis Therapeutics Clinical Trials 30
    Prominent Drugs 32
    Clinical Trial Profile Snapshots 33
    Appendix 132
    Abbreviations 132
    Definitions 132
    Research Methodology 133
    Secondary Research 133
    About GlobalData 134
    Contact Us 134
    Source 134

    List of Tables
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Region, 2017-6
    Chronic Bronchitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017-8
    Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017-9
    Chronic Bronchitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017-10
    Chronic Bronchitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017-11
    Chronic Bronchitis Therapeutics Clinical Trials, North America, Top Countries, 2017-12
    Chronic Bronchitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017-13
    Chronic Bronchitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017-14
    Proportion of Chronic Bronchitis to Respiratory Clinical Trials, G7 Countries (%), 2017-15
    Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017-16
    Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017-17
    Proportion of Chronic Bronchitis to Respiratory Clinical Trials, E7 Countries (%), 2017-18
    Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017-19
    Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017-20
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Phase, 2017-21
    Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017-22
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Trial Status, 2017-24
    Chronic Bronchitis Therapeutics Clinical Trials, Global, by End Point Status, 2017-25
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
    Chronic Bronchitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017-27
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017-29
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017-31
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017-32

    List of Figures
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Region (%), 2017-6
    Chronic Bronchitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017-7
    Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017-9
    Chronic Bronchitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017-10
    Chronic Bronchitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017-11
    Chronic Bronchitis Therapeutics Clinical Trials, North America, Top Countries (%), 2017-12
    Chronic Bronchitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017-13
    Chronic Bronchitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017-14
    Proportion of Chronic Bronchitis to Respiratory Clinical Trials, G7 Countries (%), 2017-15
    Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017-16
    Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017-17
    Proportion of Chronic Bronchitis to Respiratory Clinical Trials, E7 Countries (%), 2017-18
    Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017-19
    Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017-20
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Phase (%), 2017-21
    Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017-22
    Chronic Bronchitis Therapeutics, Global, Clinical Trials by Trial Status, 2017-23
    Chronic Bronchitis Therapeutics Clinical Trials, Global, by End Point Status, 2017-25
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
    Chronic Bronchitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017-27
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017-28
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017-30
    Chronic Bronchitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017-32
    GlobalData Methodology 133
    Novartis AG
    C. H. Boehringer Sohn AG & Co KG
    GlaxoSmithKline Plc
    Torrent Pharmaceuticals Ltd
    Bayer AG
    AstraZeneca Plc
    Melinta Therapeutics Inc
    Sanofi
    Mylan NV
    Meiji Seika Pharma Co Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//chronic-bronchitis-global-clinical-trials-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//chronic-bronchitis-global-clinical-trials-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//chronic-bronchitis-global-clinical-trials-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments